SCHEMBL6973837

SCHEMBL6973837

CCN(Cc1ccc(Cl)cc1)c1nnc(-c2c(C)cc(C)cc2C)c2ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 8/20 0.39
CNR2 P34972 7/20 0.36
CNR1 P21554 6/20 0.36
THRB P10828 1/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C19 P33261 2/20 0.36
MEN1 O00255 1/20 0.36
CYP2C9 P11712 1/20 0.36
KMT2A Q03164 1/20 0.36
CHRM2 P08172 1/20 0.34
ADRA2A P08913 1/20 0.34
CYP2D6 P10635 1/20 0.34
CHRM1 P11229 1/20 0.34
TSHR P16473 1/20 0.34
DRD1 P21728 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
ADRA1A P35348 1/20 0.34
OPRM1 P35372 1/20 0.34
DRD3 P35462 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2046515 0.90 CRHR1 (0.46) CRHR1CNR2CYP2C19TSHR
SCHEMBL6964070 0.85 CRHR1 (0.38) CRHR1
SCHEMBL6968784 0.81 NR1H2 (0.38) CRHR1CYP2C19MEN1CYP2C9KMT2A
SCHEMBL2019659 0.79 CRHR1 (0.51) CRHR1
SCHEMBL6968788 0.79 CRHR1 (0.45) CRHR1
SCHEMBL2018947 0.78 CRHR1 (0.41) CRHR1CYP1A2CYP2C19MEN1CYP2C9
SCHEMBL6963411 0.78 CRHR1 (0.51) CRHR1
SCHEMBL2016765 0.75 GABRA1 (0.46) CRHR1KMT2ATSHR
SCHEMBL2024545 0.74 C5AR1 (0.43) MEN1KMT2ATSHR
SCHEMBL2019402 0.73 CRHR1 (0.43) CRHR1CNR2CNR1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0946520-B1 ISOQUINOLINAMINE AND PHTHALAZINAMINE DERIVATIVES WHICH INTERACT WITH CRF RECEPTORS NEUROGEN CORP (US) 2003-04-02 EP claimed
EP-0946520-B1 ISOQUINOLINAMINE AND PHTHALAZINAMINE DERIVATIVES WHICH INTERACT WITH CRF RECEPTORS NEUROGEN CORP (US) 2003-04-02 EP disclosed